Cite
APA Citation
Tolcher, A., Papadopoulos, K., Cole, Y., Rivas, K., Chandana, S., Sinclair, S., Wood, D., Nadler, P. I., & Lakhani, N. (n.d.). 46OA Phase 1a/2a trial of AVID100, an anti-EGFR antibody-drug conjugate. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095490313.0x00002d